Acadia Pharmaceuticals Inc. (ACAD) earnings

Earnings (net income) · fiscal 2025
$391.00M

Acadia Pharmaceuticals Inc. (ACAD) reported net income of $391.00M in fiscal 2025 (the year ended December 31, 2025). That is 72.7% higher than the $226.45M of fiscal 2024. Figures as of 18 Nov 2026, 01:24 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$391.00M
Change on fiscal 2024
+72.7%
Highest on record
$391.00Mfiscal 2025
Lowest on record
-$289.40Mfiscal 2017
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Acadia Pharmaceuticals Inc. earnings, in more detail

Across the 17 fiscal years on record (2009–2025), the highest was $391.00M in fiscal 2025 and the lowest -$289.40M in fiscal 2017.

History · 17 fiscal years

Earnings (net income) by fiscal year

Acadia Pharmaceuticals Inc. earnings, year by year

Acadia Pharmaceuticals Inc. (ACAD) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$391.00M 72.7% up
2024$226.45M—
2023-$61.29M—
2022-$215.98M—
2021-$167.87M—
2020-$281.58M—
2019-$235.26M—
2018-$245.19M—
2017-$289.40M—
2016-$271.39M—
2015-$164.44M—
2014-$92.48M—
2013-$37.95M—
2012-$20.85M—
2011-$22.77M 250.4% down
2010$15.14M—
2009-$45.15M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

More on ACAD

Acadia Pharmaceuticals Inc., figure by figure

Acadia Pharmaceuticals Inc. (ACAD) overview: price, valuation and scorecard

Acadia Pharmaceuticals Inc. earnings: questions and answers

What is Acadia Pharmaceuticals Inc.'s net income?

Acadia Pharmaceuticals Inc. (ACAD) reported net income of $391.00M in fiscal 2025 (the year ended December 31, 2025). That is 72.7% higher than the $226.45M of fiscal 2024.

What are the highest and lowest net income figures on record for Acadia Pharmaceuticals Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $391.00M in fiscal 2025 and the lowest -$289.40M in fiscal 2017.

How is Acadia Pharmaceuticals Inc.'s net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Acadia Pharmaceuticals Inc. (ACAD) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/ACAD/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.